Six takeaways from the CMS administrator’s appearance at a D.C. think tank Monday — including who’s set to be the next ...

The sale will leave Owens & Minor focused on a smaller but potentially faster-growing and higher-margin business that ...

At AdvaMed’s annual conference, CEO Scott Whitaker addressed policy issues around tariffs, FDA staff cuts and the ongoing ...

Executives from Stryker and Johnson & Johnson are on the hunt for deals, despite a turbulent environment, they said at ...

Capacity at the company's Boston site will increase by 50% as part of a $600 million, 10-year commitment to the U.S.

At AdvaMed’s The MedTech Conference, executives said they’re incorporating AI in more devices, but figuring out how to use ...

MedSec CEO Michelle Jump spoke with MedTech Dive at AdvaMed’s annual meeting about the FDA’s shift from a “carrot” to a ...

The Sanofi partnership will support clinical validation and regulatory submissions for Revvity’s new assay. Elsewhere, ...

Boston Scientific also foresees future growth in its Watchman business from a planned label expansion and concomitant ...

The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.

The company has now treated 500,000 patients with its pulsed field ablation system, in a competitive category poised for ...

Implementing artificial intelligence requires significant human labor and technical expertise, threatening to create a ...